
|Poll|September 29, 2015
"Up the Price by How Much?"
Author(s)Consultantlive Staff
Turing Pharmaceutical's CEO has backed down on the 4000% price hike for Daraprim, but is the damage done? Take our poll.
Advertisement
You’ve read about Turing Pharmaceuticals’ recent attempt to increase the cost of Daraprim by about 4000%.
Do you think this move is:
Newsletter
Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.
Advertisement





































































































































































































